24 results
IDSA Recommendations for Preventing Human Papillomavirus Infections and Cervical Cancer Screening for Women with in HIV-AIDS
Recommendations
IDSA Recommendations ... screen within 1 ... HumanPapillomavirus #IDSA ... #Prevention #Treatment ... #HIVAIDS #pharmacology
C.diff - Clostridioides Difficile Infection (CDI) - Diagnosis and Management - GrepMed Handbook

Clinical Presentation + Progression:
(CDI) - Diagnosis ... Tx Management (IDSA ... 10 mg/kg IV x 1 ... IDSA 2021 CDI ... #IDSA #gastroenterology
IDSA Recommendations for Preventing and Treating Penicillium marneffei Infections in HIV-AIDS
Preventing 1st Episode of Penicilliosis (Primary
IDSA Recommendations ... in HIV-AIDS Preventing ... Penicilliosis #IDSA ... #Prevention #Treatment ... #HIVAIDS #pharmacology
Microbial Etiology of Acute Pharyngitis - IDSA
Bacterial
 • Group A streptococcus - Pharyngotonsillitis, scarlet fever
 •
Pharyngitis - IDSA ... peritonsillar abscess ... simplex virus 1 ... #Pharyngitis #IDSA ... #diagnosis #differential
IDSA Recommendations for Preventing and Treating Bacterial Enteric Infections in HIV-AIDS
Preventing Bacterial Enteric Illness:
 • Antimicrobial
IDSA Recommendations ... (CDI): • Vancomycin ... Enteric #Bacterial #IDSA ... #Prevention #Treatment ... #HIVAIDS #pharmacology
IDSA Recommendations for Treating Herpes Simplex Virus (HSV) Infections in HIV-AIDS
Treating Orolabial Lesions (Duration: 5–10 days)
IDSA Recommendations ... • Valacyclovir 1 ... • Valacyclovir 1 ... #IDSA #Prevention ... #HIVAIDS #pharmacology
IDSA Recommendations for Preventing and Treating Toxoplasma gondii Encephalitis in HIV-AIDS
Indications for Initiating Primary Prophylaxis:
 •
IDSA Recommendations ... #Encephalitis #IDSA ... #Prevention #Treatment ... opportunistic #infections ... #HIVAIDS #management
IDSA Recommendations for Treating Isospora belli Infection in HIV-AIDS
Treating Isospora belli Infection
General Management Considerations:
 • Fluid
IDSA Recommendations ... in HIV-AIDS Treating ... IsosporaBelli #IDSA ... #Prevention #Treatment ... #HIVAIDS #pharmacology
IDSA Recommendations for Treating Coccidiodomycosis in HIV-AIDS
Treating Mild Infections (Such As Focal Pneumonia or asymptomatic patients
IDSA Recommendations ... positive serology and CD4 ... Coccidiodomycosis #IDSA ... #Prevention #Treatment ... #HIVAIDS #pharmacology
IDSA Recommendations for Treating Mucosal Candidiasis in HIV-AIDS
Oropharyngeal Candidiasis: Initial Episodes (Duration of Therapy: 7–14 days)
Preferred
IDSA Recommendations ... 4–6 mL QID or 1– ... candida #mucosal #IDSA ... opportunistic #infections ... #HIVAIDS #pharmacology